Fundz

Fundz Deep Dive

Everything you need to win Martin Fitchet — in one platform.

Who to reach, what to say, and why now on Martin Fitchet — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Martin Fitchet — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Medicines for Malaria Venture Appoints Martin Fitchet Md As Chief Executive Officer

PRIVATEApr 18, 2024•about 2 years ago

Position

Chief Executive Officer

Company

MEDICINES for Malaria Venture

Martin Fitchet
GenevaBiotechnologyHealth CareNon Profit

Description

MEDICINES for Malaria Venture (MMV) has announced the appointment of Martin Fitchet MD as its new Chief Executive Officer. Martin brings over 25 years of experience across Pharmaceuticals, MedTech and Global Public Health and joins from Johnson & Johnson where he was most recently the Global Head of Global Public Health.

Company Information

Company

MEDICINES for Malaria Venture

Location

Geneva, Geneva, Switzerland

About

MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries.

Predictive Intelligence
Strategic

ML-powered predictions for MEDICINES for Malaria Venture's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.